Skip to Main Content

Paper Details

Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas.
Clin Transl Med
8
2020
ADC, ADCs, human, lung ADC, lung ADCs, lung adenocarcinoma, lung adenocarcinomas, mRNA, normal, normal specimens, patients, tumor
Author NameAffiliation
Melinda RezeliClinical Protein Science and Imaging, Biomedical Center, Lund University
Gy??rgy Marko-VargaClinical Protein Science and Imaging, Biomedical Center, Lund University
Gy??rgy Marko-VargaClinical Protein Science and Imaging, Biomedical Center, Lund University
  • 1 - 3

Datasets

Release 1.2